Amgen 2015 Annual Report Download - page 127
Download and view the complete annual report
Please find page 127 of the 2015 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117 -
118 -
119 -
120 -
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128 -
129 -
130 -
131 -
132
 |
 |
F-49
December 31,
2015 2014
Long-lived assets:
United States $ 2,275 $ 2,544
Puerto Rico 1,679 1,771
ROW 953 908
Total long-lived assets $ 4,907 $ 5,223
Major customers
In the United States, we sell primarily to pharmaceutical wholesale distributors. We utilize those wholesale distributors as
the principal means of distributing our products to healthcare providers. Outside the United States, we sell principally to healthcare
providers and/or pharmaceutical wholesale distributors depending on the distribution practice in each country. We monitor the
financial condition of our larger customers, and we limit our credit exposure by setting credit limits and, in certain circumstances,
by requiring letters of credit.
We had product sales to three customers each accounting for more than 10% of total revenues for each of the years ended
December 31, 2015, 2014 and 2013. For 2015, on a combined basis, these customers accounted for 81% and 97% of worldwide
gross revenues and U.S. gross product sales, respectively, as noted in the following table. Certain information with respect to these
customers was as follows (dollar amounts in millions):
Years ended December 31,
2015 2014 2013
AmerisourceBergen Corporation:
Gross product sales $ 10,038 $ 9,142 $ 8,527
% of total gross revenues 34% 34% 35%
% of U.S. gross product sales 42% 43% 44%
McKesson Corporation:
Gross product sales $ 8,766 $ 8,011 $ 6,440
% of total gross revenues 30% 30% 27%
% of U.S. gross product sales 34% 35% 32%
Cardinal Health, Inc.:
Gross product sales $ 5,045 $ 3,407 $ 3,209
% of total gross revenues 17% 13% 13%
% of U.S. gross product sales 21% 16% 17%
At December 31, 2015 and 2014, amounts due from these three customers each exceeded 10% of gross trade receivables
and accounted for 75% and 69%, respectively, of net trade receivables on a combined basis. At December 31, 2015 and 2014, 23%
and 30%, respectively, of trade receivables, net, were due from customers located outside the United States, primarily in Europe.
Our total allowance for doubtful accounts as of December 31, 2015 and 2014, was not material.